Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | BLM | P54132 | 3/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2741115 | 0.69 | ALDH1A1 (0.40) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL21463 | 0.69 | MAPT (0.41) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL10946058 | 0.67 | KDM4E (0.31) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL6528241 | 0.65 | MIF (0.50) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL11434480 | 0.65 | ALDH1A1 (0.40) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL17581128 | 0.63 | — | — | |
| Duroquinone SCHEMBL11408085 | 0.63 | DDAH1 (0.36) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL12658461 | 0.63 | — | — | |
| SCHEMBL361072 | 0.63 | TYR (0.39) | MEN1ALDH1A1KMT2AMAPTMAPK1 | |
| SCHEMBL4400936 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809431-B2 | Process for stabilizing olefinically unsaturated monomers | EVONIK DEGUSSA GMBH (DE) | 2014-08-19 | — | — | US | disclosed |
| US-20120101295-A1 | PROCESS FOR STABILIZING OLEFINICALLY UNSATURATED MONOMERS | EVONIK DEGUSSA GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| US-8128804-B2 | Process for stabilizing olefinically unsaturated monomers | EVONIK DEGUSSA GMBH (DE) | 2012-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101295-A1 | PROCESS FOR STABILIZING OLEFINICALLY UNSATURATED MONOMERS | SQOR, ALOX12, ALOX15B | MEN1 1504/4885ALDH1A1 325/4885KMT2A 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.